Gerard Criner, MD: Spiration Valve System Shows Sustained Im

Criner and colleagues concluded that the 5-year results from the EMPROVE trial demonstrated that Spiration Valve System (SVS) treatment was safe and durable, effectively improving lung function in patients with emphysema

Related Keywords

Washington , United States , American , Gerard Criner , Temple University Health System Lung Center , Trial Investigator Group , American Thoracic Society Annual Meeting , National Emphysema Treatment Trial , Temple Health Gerard Criner , Department Of Thoracic Surgery , Temple Health , Thoracic Surgery , Spiration Valve System , Long Term Benefits , Valve System , Emphysema Patients , Year Results ,